Bolt Biotherapeutics Inc (BOLT)
1.16
-0.04
(-3.35%)
USD |
NASDAQ |
Apr 25, 16:00
Bolt Biotherapeutics Price to Book Value: 0.3923 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.3923 |
| April 24, 2024 | 0.4059 |
| April 23, 2024 | 0.3754 |
| April 22, 2024 | 0.3754 |
| April 19, 2024 | 0.3754 |
| April 18, 2024 | 0.3855 |
| April 17, 2024 | 0.3754 |
| April 16, 2024 | 0.3889 |
| April 15, 2024 | 0.3822 |
| April 12, 2024 | 0.4058 |
| April 11, 2024 | 0.4295 |
| April 10, 2024 | 0.4227 |
| April 09, 2024 | 0.4346 |
| April 08, 2024 | 0.4633 |
| April 05, 2024 | 0.4498 |
| April 04, 2024 | 0.4498 |
| April 03, 2024 | 0.4566 |
| April 02, 2024 | 0.4735 |
| April 01, 2024 | 0.5073 |
| March 28, 2024 | 0.4735 |
| March 27, 2024 | 0.4126 |
| March 26, 2024 | 0.4024 |
| March 25, 2024 | 0.4058 |
| March 22, 2024 | 0.4058 |
| March 21, 2024 | 0.3923 |
| Date | Value |
|---|---|
| March 20, 2024 | 0.3923 |
| March 19, 2024 | 0.3889 |
| March 18, 2024 | 0.3855 |
| March 15, 2024 | 0.3754 |
| March 14, 2024 | 0.372 |
| March 13, 2024 | 0.3906 |
| March 12, 2024 | 0.4243 |
| March 11, 2024 | 0.4277 |
| March 08, 2024 | 0.4479 |
| March 07, 2024 | 0.4209 |
| March 06, 2024 | 0.4209 |
| March 05, 2024 | 0.4142 |
| March 04, 2024 | 0.4277 |
| March 01, 2024 | 0.4075 |
| February 29, 2024 | 0.3839 |
| February 28, 2024 | 0.4007 |
| February 27, 2024 | 0.4041 |
| February 26, 2024 | 0.4108 |
| February 23, 2024 | 0.4108 |
| February 22, 2024 | 0.4075 |
| February 21, 2024 | 0.3822 |
| February 20, 2024 | 0.3873 |
| February 16, 2024 | 0.4041 |
| February 15, 2024 | 0.3805 |
| February 14, 2024 | 0.3704 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2313
Minimum
May 06 2022
3.943
Maximum
Mar 31 2021
0.7243
Average
0.3789
Median
Apr 19 2023
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.876 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6630 |
| Theriva Biologics Inc | 0.1949 |
| Oragenics Inc | 3.129 |
Price to Book Value Related Metrics
| PS Ratio | 5.569 |
| Price | 1.16 |
| Earnings Yield | -157.8% |
| Market Cap | 44.23M |